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Abstract
Introduction
Patients with complex health care needs (PCHCN) are individuals who require numerous,
costly care services and have been shown to place a heavy burden on health care
resources. It has been argued that an important issue in providing value-based primary care
concerns how to identify groups of patients with similar needs (who pose similar challenges)
so that care teams and care delivery processes can be tailored to each patient subgroup.
Our study aims to describe the most common chronic conditions and their combinations in a
cohort of elderly PCHCN.
Methods
We focused on a cohort of PCHCN residing in an area served by a local public health unit
(the “Azienda ULSS4-Veneto”) and belonging to Resource Utilization Bands 4 and 5 accord-
ing to the ACG System. For each patient we extracted Expanded Diagnosis Clusters, and
combined them with information available from Rx-MGs diagnoses. For the present work
we focused on 15 diseases/disorders, analyzing their combinations as dyads and triads.
Latent class analysis was used to elucidate the patterns of the morbidities considered in the
PCHCN.
Results
Five disease clusters were identified: one concerned metabolic-ischemic heart diseases;
one was labelled as neurological and mental disorders; one mainly comprised cardiac dis-
eases such as congestive heart failure and atrial fibrillation; one was largely associated with
respiratory conditions; and one involved neoplasms.
Conclusions
Our study showed specific common associations between certain chronic diseases,
shedding light on the patterns of multimorbidity often seen in PCHCN. Studying these
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Introduction
Patients with complex health care needs (PCHCN) are individuals whose care requirements are
numerous and costly, and they have been shown to place a heavy burden on health care resources
[1]. This may be an over-simple definition, however, and efforts in the US to better classify
PCHCN have shown that this group mainly consists of frail elderly people or individuals with
multimorbidity. This term refers to the co-occurrence of multiple chronic or acute diseases with-
out any one disease being taken for reference, whereas comorbidity is usually defined in relation
to a given index condition [2]. According to Schellevis, comorbidity can also be classified by the
relationship between the different diseases [3]: concurrent comorbidity defines the random coex-
istence of diseases; cluster comorbidity indicates statistically significant associations between dis-
eases without a causal explanation; causal comorbidity describes disease clustering with a
pathophysiological relationship between the different diseases (e.g. shared risk factors); and com-
plicating comorbidity illustrates the case when one disease is caused by another, and cannot be
explained without its precursor [3–4]. Multimorbidity poses new challenges to health care ser-
vices, which have traditionally focused on one disease at a time. Several research methods have
been used to shed light on the complexity of multimorbidity, based on the fundamental assump-
tion that health outcomes in patients with multimorbidity are largely influenced by their single
diseases with potential add-on effects of interactions between them [5]. There is evidence to sug-
gest that chronic conditions form clusters [6], and a patient-by-patient measure of such clusters of
morbidities is essential to both the funding of medical care and the planning of prevention and
treatment services. In elderly patients, understanding the relationship between concomitant dis-
eases may help us to develop strategies to improve clinical practice and prevention measures [7].
The disease clusters approach could also serve in prioritizing the development of new multimor-
bidity guidelines for the most common diseases and combinations thereof [8].
On the other hand, targeting patients on the basis of cost alone, without considering their
personal characteristics and needs, might not properly identify those for whom an interven-
tion for example of case -management would be most effective [9]. In fact, many unsuccessful
programs enroll large percentages of people who are unlikely to benefit from the intervention.
Simply being high-need/high-cost is not always enough stratification method. So there has
been a growing interest in targeting the needs of these PCHCN populations, and those of pop-
ulations at risk of joining their ranks with a view to designing tailored health care models capa-
ble of improving these patients’ health outcomes while containing the related costs [10]. It has
been argued that an important factor in providing value-based primary care concerns how to
identify groups of patients with similar needs (who pose similar challenges) so that care teams
and care delivery processes can be tailored to different patient subgroups [11].
In a population of elderly PCHCN, our study aimed to identify their multiple chronic con-
ditions (multimorbidity) and how they were combined (as dyads or triads) in an effort to pro-
vide a better epidemiological picture of this high-need clinical group.
Materials and methods
Context
The Italian NHS (National Health System) is a public system financed mainly by general taxa-
tion. It is grounded on fundamental values of universality, free access, freedom of choice,
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pluralism in provision, and equity. Regional authorities plan and organize health care facilities
and activities through their regional health departments in accordance with a national health
plan designed to assure an equitable provision of comprehensive care throughout the country.
The regional authorities coordinate and control local health units (LHU), each of which is a
separate geographically based public company delivering public health, promotion and com-
munity health services, primary care and hospital care, either with their own facilities and per-
sonnel or through outside contractors [12]. The Veneto Regional Health Service has 21 such
LHUs serving a population of about five million. The LHU involved in the present study was
the “Azienda ULSS4-Veneto”, which serves a population of about 190,000 in the province of
Vicenza, in northeastern Italy.
The ACG System was implemented in the Veneto Region in 2012 as a tool for population
risk stratification [13–15]. The ACG System is a method used internationally to characterize
multimorbidity on the strength of routinely collected administrative data (e.g. hospitalization
records, pharmaceutical prescriptions, access to emergency departments, prescriptions charge
exemptions) gathered together using record linkage. It relies on an algorithm that starts from
individual-level diagnoses and is based on the clinical judgement of likelihoods (persistence or
recurrence over time, demand for specialist services, hospitalization, disability or decline in
quality of life, expected need for and use of diagnostic or therapeutic procedures), then
adjusted for age and gender, to group a population by 93 mutually-exclusive combinations of
conditions, or ACG (Adjusted Clinical Groups) that represent clinically logical categories of
patients expected to require similar levels of health care resources [16]. Based on usage of care
resources, the ACG System automatically collapses the different ACG categories into six
Resource Utilization Bands (RUBs), which are defined as follows: 0, nonuser or invalid diagno-
sis; 1 healthy user; 2 low morbidity; 3 moderate morbidity; 4 high morbidity; 5 very high mor-
bidity [17]. The ACG database is owned by the single LHUs and the Veneto Region’s
Epidemiological Services, which may provide researchers with anonymized data for study
purposes.
The present study only concerned patients aged 65 years or more residing in the area served
by the LHU “Azienda ULSS4-Veneto”, and characterized by complex health care needs
(PCHCN patients), corresponding to RUBS 4 and 5. For each individual considered, we
extracted EDC (Expanded Diagnosis Clusters), which coincide with the clinical diagnosis that
the ACG system assigns to single patients by combining different information flows. To
improve the sensitivity of our model, patients with chronic conditions were also identified by
means of the information available from the Pharmacy (RX)-based Morbidity Marker Groups
(Rx-MGs), and the clinical criteria used to assign medication to different morbidity groups.
The Rx-MGs provide further methods for describing the particular morbidity profile of a
given population and form the basis of the pharmacy-based predictive model [17]. A dichoto-
mous variable was thus assigned to each chronic disease (1 if one of the EDCs or Rx-MGs were
involved, 0 otherwise). Cases of neoplastic disease, Alzheimer’s disease, fibrillation and cere-
brovascular disease were only discernible from the ECD codes, while cases of hyperlipidemia
could only be obtained from the Rx-MGs.
Unfortunately, no standard exists for measuring multimorbidity, so the choice of morbidi-
ties to consider is always inevitably rather subjective and depends on the data available [18].
This study focused on a subset of conditions including: cancer, congestive heart failure, ische-
mic heart disease, high blood pressure (HBP), atrial fibrillation, hyperlipidemia, cerebrovascu-
lar disease, Alzheimer’s disease, depression, asthma/bronchitis, diabetes, chronic obstructive
pulmonary disease, osteoporosis, hypothyroidism, and chronic renal disease.
In addition to the disease-specific variables, patients’ age was also considered, grouped into
the following age brackets: “65–69”, “70–74”, “75–79”, “80–84”, “85+”.
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Statistical methods
Frequencies and percentages were used for the descriptive analysis. A first bubble graph was
constructed to show the estimated proportions of patients with each dyad of diseases–the
larger the bubble, the higher the observed prevalence of a given dyad. Then a second bubble
graph was used to indicate the magnitude of the association, measured with the chi2 statistic.
The prevalence was calculated for the most common disease dyads (for which the observed
prevalence was at least 20%), and, the association between the diseases comprising each dyad
was estimated by means of odds ratios and their 95% confidence intervals. To see whether
these prevalences were greater than might be expected, the observed-to-expected prevalence
ratio were also calculated (given the prevalence of each disease in the population, the expected
prevalence of a given disease dyad is estimated by assuming that the two diseases occur inde-
pendently). The same was done for the most common disease triads (and we report those with
an observed prevalence of at least 10%). The most common triads were counted in terms of
absolute frequency, and per 100 respondents. The observed-to-expected prevalence ratios are
reported with 95% confidence intervals.
A cluster analysis was undertaken on the variables to identify clinically meaningful groups
of chronic diseases. A key concept in clustering is dissimilarity, and the problem is how to
measure it properly: Jaccard’s distance was adopted here because the variables in question are
dichotomous (the presence or absence of a given disease). It was appropriate to analyze clusters
of variables with the hierarchical clustering approach because many chronic diseases share the
same underlying genetic, environmental or behavioral risk factors. The complete linkage crite-
rion was used to measure the distances between clusters because it led to the best result. An
advantage of hierarchical clustering on variables is that the outcome can easily be represented
by means of a dendrogram.
An exploratory latent class analysis (LCA—a tool appropriate for analyzing categorical
data) was undertaken to classify patients in a number K of classes, which had to be defined a-
priori. The number was chosen using the Bayesian information criterion (BIC). Ten different
models were delineated, characterized by an increasing number of classes (from one to ten),
and the model that gave rise to the smallest BIC index was adopted. The model with five latent
classes was consequently chosen, which led to a BIC of 40,488.50.
Ethical considerations
The data analysis was performed on anonymized aggregate data with no chance of individuals
being identifiable. The study complied with the Declaration of Helsinki and with Italian Law
n. 196/2003 on the protection of personal data. The recent resolution n. 85/2012 of the Italian
Guarantor for the Protection of Personal Data also confirmed the allowability of processing
personal data for medical, biomedical and epidemiological research, and that data concerning
health status may be used in aggregate form in scientific studies. Permission to use unidentifi-
able individual data extracted from administrative databases was granted by the ex-ULSS 4,
Veneto Region.
Results
Our analysis was conducted on data drawn from a population of 185,887, selecting 39,643
individuals aged 65 years old or more, including 2,691 who were PCHCN on the grounds of
the ACG: 2,250 (84%) were RUB 4, and 441 (16%) were RUB 5.
Table 1 provides demographic details of the study population, the proportion of those
with multimorbidity and the proportion with multimorbidity. Among the PCHCN, the num-
ber of diseases involved and the proportion of people with multimorbidity did not increase
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substantially with age (Fig 1): at 65–69 years old, 95% of the sample already had more than one
morbidity.
Fig 2A shows the observed prevalence of the disease dyads in PCHCN. As hypertension
and congestive heart failure both have a high prevalence (88% and 63%, respectively), this
dyad was found in 57% of patients.
Fig 2B shows the observed power of the associations between disease dyads among these
patients. The most powerful associations were found between ischemic heart disease and
hyperlipidemia, and between chronic obstructive pulmonary disease and asthma.
Tables 2 and 3 show the most common disease dyads before (Table 2) and after (Table 3)
excluding hypertension and congestive heart failure, the latter in an effort to identify other
interesting dyads among the less common diseases.
Table 4 shows disease triads for which the observed prevalence was at least 10%, in declin-
ing order. The hypertension, congestive heart failure and fibrillation triad, and the ischemic
heart disease, hypertension and hyperlipidemia triad revealed the greatest differences between
the expected prevalence (assuming the diseases occurred independently of one another) and
Table 1. Morbidity and multimorbidity in PCHCN.
N (%) Mean number of
morbidities
Percentage (95% CI) with
multimorbidity
Percentage (95% CI) with multimorbidity involving both physical not
neurological and neurological/mental health˚
ALL
PATIENTS
2691
(100.00%)
4.55 (1.72) 97.43% (96.84–98.03) 56.08% (54.20–57.95)
SEX
Female 1384
(48.57%)
4.54 (1.67) 97.32% (96.71–97.93) 60.69% (58.12–63.27)
Male 1307
(51.43%)
4.55 (1.77) 97.54% (96.96–98.13) 51.19% (48.48–53.90)
AGE
65–69 282 (10.48%) 4.05 (1.78) 95.04% (94.21–95.86) 40.78% (35.04–46.52)
70–74 427 (15.86%) 4.41 (1.75) 96.01% (95.28–96.76) 45.20% (40.48–49.92)
75–79 575 (21.37%) 4.59 (1.80) 97.04% (96.40–97.68) 52.52% (48.44–56.60)
80–84 564 (20.96%) 4.81 (1.72) 98.58% (98.13–99.03) 59.57% (55.52–63.62)
85+ 843 (31.33%) 4.58 (1.58) 98.46% (97.99–98.92) 66.79% (63.61–69.96)
NUMBER OF DISORDERS
N (%) Cumulative
frequencies
Percentage (95% CI) with multimorbidity involving both physical not
neurological and neurological/mental health˚
0 4 (0.15%) 0.15% -
1 65 (2.42%) 2.57% -
2 241 (8.96%) 11.53% 31.54% (25.67–37.40)
3 457 (16.98%) 28.51% 46.17% (41.60–50.74)
4 583 (21.66%) 50.17% 51.80% (47.74–55.86)
5 581 (21.59%) 71.76% 61.45% (57.49–65.40)
6 423 (15.72%) 87.48% 69.03% (64.62–73.44)
7 203 (7.54%) 95.02% 77.34% (71.58–83.10)
8 97 (3.60%) 98.62% 84.54% (77.34–91.73)
9 27 (1.00%) 99.62% 81.48% (66.83–96.13)
10 10 (0.37%) 100.0% 100.00% (—)
˚Morbidities involving the physical health: cancer, coronary heart disease, diabetes mellitus, high blood pressure, heart failure, chronic obstructive pulmonary disease,
chronic kidney disease, atrial fibrillation, asthma, osteoporosis, hypothyroidism, hyperlipidemia. Morbidities involving the neurological/mental health: Alzheimer’s
disease, cerebrovascular disease, depressive disorder.
https://doi.org/10.1371/journal.pone.0208875.t001
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the observed prevalence. Other triads revealed a significantly higher observed than expected
prevalence too, demonstrating that disease triads are associated in their occurrence, even if the
analysis cannot clarify how the diseases are related.
The result of hierarchical clustering on the variables is shown in a dendrogram (Fig 3). Five
clusters are detectable, two of them clearly distinct (one comprising Alzheimer’s disease, cere-
brovascular disease and depression, the other including chronic obstructive pulmonary disease
and asthma). A larger cluster contains ischemic heart disease, diabetes, hypertension, conges-
tive heart failure, fibrillation and neoplasms. Chronic renal failure and osteoporosis also form
a cluster, while hypothyroidism seems to have no strong association with any of the other dis-
eases considered here.
Table 5 shows the outcome of the model, with the class conditional probabilities for each
disease. Ischemic heart disease, diabetes, hypertension and hyperlipidemia seem to be preva-
lent in the first class (which could be labelled as Cardiovascular disease), while the second is
characterized by higher probabilities of Alzheimer’s disease, cerebrovascular disease and
depression (and could be called Neurological and mental illness). Congestive heart failure and
fibrillation have higher class-conditional probabilities related to Class 3 (Cardiac disease), and
Class 4 includes the majority of patients with asthma and chronic obstructive pulmonary
Fig 1. Number of chronic disorders by age group.
https://doi.org/10.1371/journal.pone.0208875.g001
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disease (the two Respiratory diseases considered here). The chronic diseases in Class 4 have
very low class-conditional probabilities by comparison with the other classes. Patients with
Fig 2. Bubble chart. (a) Bubble chart for the prevalences observed. A larger bubble indicates a higher observed prevalence of the dyad. (b) Bubble chart for the
associations between chronic diseases, measured with the chi2 statistic. A larger bubble indicates a stronger association between the diseases. CAN = cancer;
CHD = coronary heart disease; AD = Alzheimer’s disease; CVD = cerebrovascular disease; DM = diabetes mellitus; HBP = high blood pressure; HF = heart failure;
COPD = chronic obstructive pulmonary disease; CKD = chronic kidney disease; DD = depressive disorder; AF = atrial fibrillation; ASTH = asthma; OP = osteoporosis;
HT = hypothyroidism; HL = hyperlipidemia.
https://doi.org/10.1371/journal.pone.0208875.g002
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neoplasms are only prevalent in the fifth and last class (which was consequently labelled as
Cancer). Hypertension and congestive heart failure clearly have high class-conditional proba-
bilities for more than one class, since they are the diseases with the highest prevalence in our
dataset. On the other hand, chronic renal failure, osteoporosis and hypothyroidism feature low
class-conditional probabilities for any of the five classes, confirming the weak association
between these diseases and the other conditions considered here. Generally speaking, LCA
produced results consistent with the cluster analysis on the variables.
Discussion and conclusions
Our study found consistent associations and sheds light on the patterns of multimorbidity
identifiable using different analytical methods in a cohort of PCHCN. Our data revealed that
nearly 90% of elderly PCHCN have at least two diseases, and more than one in three are at
least 85 years old, thus confirming how multimorbidity as an important contributor to the
Table 2. Observed and expected prevalence (assuming the diseases occur independently, and based on the prevalence of each disease in the population) of all disease
dyads with a prevalence higher than 20%. Dyads with statistically significant odds ratio are highlighted in bold.
DISEASE DYADS Prevalence / 100
Observed Expected O/E Odds ratio Confidence interval
HBP HF 57.41 55.12 1.04 2.40 (1.90, 3.03)
CVD HBP 30.66 29.71 1.03 1.52 (1.17, 1.97)
HBP AF 30.06 29.03 1.04 1.59 (1.22, 2.08)
DM HBP 28.02 27.27 1.03 1.41 (1.08, 1.84)
HBP HL 25.86 23.75 1.09 3.88 (2.67, 5.63)
HF AF 25.83 20.77 1.24 2.89 (2.40, 3.47)
HBP DD 23.23 22.96 1.01 1.14 (0.87, 1.49)
CHD HBP 23.08 21.43 1.08 2.90 (2.03, 4.14)
DM HF 21.52 19.51 1.10 1.51 (1.27, 1.79)
CAN = cancer; CHD = coronary heart disease; AD = Alzheimer’s disease; CVD = cerebrovascular disease; DM = diabetes mellitus; HBP = high blood pressure;
HF = heart failure; COPD = chronic obstructive pulmonary disease; CKD = chronic kidney disease; DD = depressive disorder; AF = atrial fibrillation; ASTH = asthma;
OP = osteoporosis; HT = hypothyroidism; HL = hyperlipidemia.
https://doi.org/10.1371/journal.pone.0208875.t002
Table 3. Observed and expected prevalence (assuming the diseases occur independently, and based on the prevalence of each disease in the population) of disease
dyads with a prevalence higher than 20%, after excluding hypertension and congestive heart failure.
DISEASE DYADS Prevalence / 100
Observed Expected O/E Odds ratio Confidence interval
CHD HL 13.97 6.60 2.12 6.39 (5.27, 7.75)
DM HL 11.04 8.40 1.31 1.82 (1.52, 2.17)
CHD DM 9.62 7.58 1.27 1.64 (1.37, 1.97)
CHD AF 9.10 8.07 1.13 1.28 (1.07, 1.54)
AD CVD 8.18 6.16 1.33 1.78 (1.46, 2.17)
COPD ASTH 7.10 2.14 3.32 9.94 (7.76, 12.73)
DD OP 6.28 4.81 1.31 1.61 (1.30, 1.98)
AD DP 6.09 4.76 1.28 1.55 (1.25, 1.91)
CAN = cancer; CHD = coronary heart disease; AD = Alzheimer’s disease; CVD = cerebrovascular disease; DM = diabetes mellitus; HBP = high blood pressure;
HF = heart failure; COPD = chronic obstructive pulmonary disease; CKD = chronic kidney disease; DD = depressive disorder; AF = atrial fibrillation; ASTH = asthma;
OP = osteoporosis; HT = hypothyroidism; HL = hyperlipidemia.
https://doi.org/10.1371/journal.pone.0208875.t003
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complexity of health care in the late stages of life. Our data also underscore how PCHCN differ
from the general elderly population, since it has been estimated that a total of 67% of Medicare
beneficiaries have multimorbidity [19]. A greater analytical detail concerning multimorbidity
in the elderly could be useful for planning treatment and prevention, and for both system-
based and patient-centered policies. In fact, the clinical utility of any intervention can be
improved by identifying particular combinations that might warrant an alternative diagnostic
or therapeutic approach. Clinicians are sometimes uncertain about how to balance of benefit
and harm of treatments for people with multimorbidity because the available evidence on
treatment options is largely based on trials of interventions for single conditions, from which
people with multimorbidity are often excluded [20]. The efficacy of more integrated
approaches to the treatment of multimorbidity should be investigated initially in patients with
specific disease combinations. Using a validated measure of multimorbidity, especially if it can
characterize different aspects of this condition, could help outpatient clinicians and discharg-
ing physicians to orient patients towards appropriate treatment programs and primary care
services (thereby improving case management, care coordination and the exploitation of a
multidisciplinary team’s skills). The present study also showed that mental health impairments
increase with age: if two in three PCHCN suffer from mental disorders (as well as physical
health issues), this complicates their management. Studies have demonstrated that patients
with mental health conditions are at risk of receiving suboptimal care for their hypertension,
diabetes, heart failure, arthritis, and chronic obstructive pulmonary disease [21–23].
Our analysis confirms that chronic conditions tend to form clusters. For example, cardio-
vascular conditions cluster with certain metabolic disorders, as already reported elsewhere
[4,24]. This association has a well-defined pathological mechanism and could be interpreted as
Table 4. Observed and expected prevalence (assuming the diseases occur independently, and based on the prevalence of each disease in the population) of disease
triads with an observed prevalence higher than 10%. Each row concerns one disease triad, and each chronic condition included in the triadi s marked with an (X). Rows
with a statistically significant difference between the observed and expected prevalences are highlighted in bold.
DISEASE TRIADS Prevalence / 100
CAN CHD AD CVD DM HBP HF COPD CKD DD AF ASTH HT OP HL O E O/E CI
X X X 24.19 24.42 0.99 (0.90, 1.09)
X X X 23.86 18.23 1.31 (1.18, 1.45)
X X X 20.07 17.13 1.17 (1.05, 1.31)
X X X 19.36 18.66 1.04 (0.93, 1.16)
X X X 16.98 13.46 1.26 (1.11, 1.43)
X X X 16.39 14.91 1.10 (0.97, 1.24)
X X X 15.79 14.42 1.10 (0.96, 1.24)
X X X 13.79 5.80 2.38 (1.99, 2.84)
X X X 12.86 12.86 1.00 (0.87, 1.15)
X X X 12.00 12.08 0.99 (0.86, 1.15)
X X X 11.71 9.12 1.28 (1.10, 1.50)
X X X 11.04 10.14 1.09 (0.93, 1.27)
X X X 11.00 9.20 1.20 (1.02, 1.40)
X X X 10.74 10.52 1.02 (0.87, 1.19)
X X X 10.59 7.38 1.43 (1.21, 1.71)
X X X 10.52 9.83 1.07 (0.91, 1.25)
CAN = cancer; CHD = coronary heart disease; AD = Alzheimer’s disease; CVD = cerebrovascular disease; DM = diabetes mellitus; HBP = high blood pressure;
HF = heart failure; COPD = chronic obstructive pulmonary disease; CKD = chronic kidney disease; DD = depressive disorder; AF = atrial fibrillation; ASTH = asthma;
OP = osteoporosis; HT = hypothyroidism; HL = hyperlipidemia.
https://doi.org/10.1371/journal.pone.0208875.t004
Multimorbidity patterns in high-need, high-cost elderly patients
PLOS ONE | https://doi.org/10.1371/journal.pone.0208875 December 17, 2018 9 / 15
an instance of causal comorbidity. Despite this evidence of clustering, guidelines on the treat-
ment of chronic disease frequently fail to consider the issue of multimorbidity. It would seem
imperative to revise guidelines on cardiovascular ischemic disease, for instance, to better
Fig 3. Dendrogram for hierarchical cluster analysis by disease. CAN = cancer; CHD = coronary heart disease;
AD = Alzheimer’s disease; CVD = cerebrovascular disease; DM = diabetes mellitus; HBP = high blood pressure;
HF = heart failure; COPD = chronic obstructive pulmonary disease; CKD = chronic kidney disease; DD = depressive
disorder; AF = atrial fibrillation; ASTH = asthma; OP = osteoporosis; HT = hypothyroidism; HL = hyperlipidemia.
https://doi.org/10.1371/journal.pone.0208875.g003
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address the most common associated morbidities. As guidelines drive care in certain settings,
they may also provide the basis for assessing quality of care, so their failure to consider multi-
morbidity can have far-reaching, adverse implications. For example, Boyd et al. examined the
applicability of US clinical guidelines to older individuals with several comorbid diseases in
2005. The study reviewed clinical guidelines for nine chronic conditions to ascertain whether
they adequately addressed the care needs of older patients with multiple comorbid diseases.
The authors found that clinical guidelines rarely addressed comorbidity, and adherence to
guideline recommendations in caring for an older person with multimorbidity would often
lead to complex and sometimes contradictory drug and self-care regimes [25]. In fact guide-
line-driven medication is taken in addition to usual prescriptions and over-the-counter drugs
for conditions such as allergies, pain, dyspepsia, and insomnia. Viewing disease-specific medi-
cation guidelines from this perspective raises the question of whether what is good for the dis-
ease is always best for the patient [26]. Guidelines that take multimorbidity interrelatedness
into account are also likely to be particularly beneficial to the geriatric community, because it
is widely accepted that patients and health care providers need to simplify and prioritize treat-
ment options in the case of multiple chronic conditions [27]. An example of one such effort is
the 2012 consensus report jointly published by the American Geriatrics Society and the Ameri-
can Diabetes Association, which provides recommendations on the treatment of diabetes in
the context of geriatric conditions such as dementia, functional impairment, and urinary
incontinence [28]. The UK guidelines include strategies to adopt in an approach to care that
takes multimorbidity into account. They suggest examining the benefits and risks of following
the recommendations for single health conditions and improving quality of life by reducing
Table 5. Class-conditional probabilities of each disease estimated with the five latent classes model. The higher class-conditional probabilities are highlighted in bold.
Disease Latent classes
Class 1
(cardiovascular)
Class 2
(Neurological and mental illness)
Class 3
(cardiac)
Class 4
(respiratory)
Class 5
(cancer)
% of respondents in each class 22.4%
(603)
19.1% (514) 30.2%
(813)
10.3%
(277)
18.0% (484)
CAN 41 17 50 28 78
CHD 64 8 22 21 8
AD 5 46 14 16 8
CVD 35 61 30 17 16
DM 44 22 33 30 26
HBP 100 82 95 84 75
HF 67 41 99 92 20
COPD 4 4 4 100 5
CKD 11 2 16 12 3
DD 26 34 25 28 18
AF 34 23 53 37 16
ASTH 12 4 15 70 12
OP 20 16 19 19 19
HT 12 7 8 9 12
HL 99 10 4 14 12
CAN = cancer; CHD = coronary heart disease; AD = Alzheimer’s disease; CVD = cerebrovascular disease; DM = diabetes mellitus; HBP = high blood pressure;
HF = heart failure; COPD = chronic obstructive pulmonary disease; CKD = chronic kidney disease; DD = depressive disorder; AF = atrial fibrillation; ASTH = asthma;
OP = osteoporosis; HT = hypothyroidism; HL = hyperlipidemia.
https://doi.org/10.1371/journal.pone.0208875.t005
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the burden of treatments, adverse events and unplanned care, and by improving the coordina-
tion of care across services [29].
There is evidence to suggest that novel models of health care, such as medical care at home
for cardiovascular patients, are needed to provide high-quality, efficient and effective care for
our growing population of PCHCN [30].
Our cluster dendrogram shows that cancer contributed most strongly to the cardiovascular
cluster. This intriguing finding might be explained by some well-known pathological mecha-
nisms that these conditions have in common. Cardiovascular disease and cancer share a num-
ber of risk factors, such as smoking, obesity, a Western diet, and a sedentary lifestyle. A better
understanding of the impact of multimorbidity and its management on cancer treatment, and
vice versa, is also much needed. In the sphere of cancer prevention procedures, for instance, it
may be that patients with multimorbidity have a cancer diagnosed earlier because they are
more frequently in contact with medical services, or later because their physicians have been
focusing only on their comorbid conditions [31].
In our patients in Class 2 (Neurological and mental illness) there was a higher conditional
probability of depression, cerebrovascular disorders and dementia. Other authors have sug-
gested an association between anxiety, depression and somatic symptoms that we are unable
to fully support [24]. The strong association between depression, other cerebrovascular condi-
tions and dementia might be due to the overlap between the psychological and neurological
domains, and related to altered mood regulating circuits secondary to vascular problems [4]. A
large body of literature has shown that: depression is common among the elderly, and associ-
ated with poor cognitive function [32]; a history of depression may confer a higher risk of
developing Alzheimer’s disease, and depression could be considered an independent risk fac-
tor for this disease [33].
Overall, our findings confirm a high prevalence of multimorbidity among PCHCN, and
point to the need for a patient-focused rather than a disease-focused management. Care plans
designed and implemented to suit the individual needs of a given patient are of the utmost
importance in order to manage and prioritize their multimorbidity. The implications down-
stream include a more efficient patient management, and better health outcomes for patients
with complex multimorbidities [34]. Recent recommendations on patients with multimorbid-
ity have focused more on general rather than disease-specific health outcomes, and on cogni-
tive assessments, non-pharmacological treatments, and minimizing the burden of treatment
for both patients and their caregivers, under the coordinated care of multidisciplinary teams
[35]. The most advanced effort to address the complex health needs of elderly patients comes
from the American Geriatrics Society (AGS), which convened an expert panel with comple-
mentary expertise on the relevant topics along with a special interest in older adults with multi-
morbidity [36]. A recent systematic review nonetheless found that it is still difficult to improve
outcomes for people with multiple conditions and suggested that intervention designed to tar-
get specific risk factors, or focusing on difficulties people experience with daily functioning
may be more effective [37]. The review concluded that further studies are needed on this topic,
particularly involving people with multimorbidity in general, and across all age groups.
The present study has many strengths, such as the use of a whole-population sample, ana-
lyzed with the aid of strongly validated software, and the comprehensive data obtained on all
diagnostic and specialist procedures, hospitalizations, drug consumptions, ED visits, and dis-
regarding patients’ insurance status (given the universal health care coverage provided by the
Italian NHS).
The main strength of our study lies in that it was population-based, thus minimizing selec-
tion bias, and independently collected data were used. The study also has several limitations,
however, which need to be considered when interpreting the findings. First of all, the use of
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administrative data may mean that some conditions are under-represented [38]. There may
not be enough data on functional status, for instance, or on chronic conditions with a high
prevalence, such as visual or hearing impairment, or chronic pain—one of the most common
conditions among patients�65 years old, and a significant burden on the management and
economic resources of the health care system [39]. On the other hand, we included some
health conditions—such as hypertension or dyslipidemia—which might be pharmacologically
mismanaged in patients with multimorbidity, particularly in the elderly [8]. An approach that
pays more attention to patient-centered measures and outcomes will be particularly important
to decision-making for patients with multiple conditions as it will focus on outcomes that span
conditions, and align treatments with common goals, which may also involve de-escalating
treatments for one condition to optimize the treatment of another if this is more likely to
achieve the patient’s goals [40].
We also tested for cluster multimorbidity by seeking any statistically significant associations
between diseases, but we were unable to reveal any causal relationships between them, or any
index diseases among them.
In conclusion, from a public health or health policy perspective, the growing burden of
multimorbidity should make it very useful to estimate not only the most frequently occurring
clusters, but also the most prevalent chronic conditions forming part of the most common pat-
terns of multimorbidity, with a view to developing interventions to cope with the growing
onslaught of the health demands of PCHCN.
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